PMID: 9555599Apr 29, 1998Paper

A meta-analysis of the effects of venlafaxine on anxiety associated with depression

Journal of Clinical Psychopharmacology
R L RudolphR Chitra

Abstract

Venlafaxine is the first member of a novel class of antidepressants that inhibits the reuptake of both serotonin and norepinephrine. Clinical trials of venlafaxine have demonstrated its efficacy and safety in the treatment of patients diagnosed with major depression. Because patients who have depression also often have anxiety, recent investigations have focused on determining whether venlafaxine can relieve symptoms of anxiety in depressed patients. We performed a pooled analysis of six short-term trials of venlafaxine, retrospectively measuring anxiety in anxious depressed patients using the Hamilton Rating Scale for Depression (HAM-D), Anxiety/Somatization factor and Anxiety Psychic item scores. Three studies were placebo-controlled, and three were placebo- and active-drug-controlled; active controls were imipramine in two trials and trazodone in the third trial. Patients were categorized as having anxiety accompanying depression if baseline HAM-D Anxiety Psychic item scores were 2 or greater. Anxious depressed patients treated with venlafaxine showed greater improvement than those treated with placebo beginning at week 3, according to the HAM-D Anxiety/Somatization factor score, and beginning at week 1, according to the Anx...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Aug 1, 1991·Archives of General Psychiatry·J OrmelG van de Willige
Oct 1, 1990·Journal of Medicinal Chemistry·J P YardleyM N James
Feb 1, 1989·Statistics in Medicine·J A BerlinT C Chalmers
Aug 1, 1972·The British Journal of Psychiatry : the Journal of Mental Science·K SchapiraC Gurney
Dec 1, 1994·Journal of Clinical Psychopharmacology·A A NierenbergJ Sullivan
Nov 1, 1994·Mayo Clinic Proceedings·E Richelson
Apr 1, 1994·Journal of Clinical Psychopharmacology·L A CunninghamE Hearst
Dec 1, 1995·Clinical Pharmacology and Therapeutics·R B D'Agostino, M Weintraub
Jan 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·M DierickA Martin
Nov 1, 1996·Journal of Biopharmaceutical Statistics·N L Geller, M Proschan
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Jun 8, 2001·Current Atherosclerosis Reports·D W Gawronski, M J Reding
Apr 7, 2004·Archives of Gerontology and Geriatrics·S Cervera-EnguixUNKNOWN TESEO Study Group
Apr 23, 2003·Biological Psychiatry·K Ranga Rama Krishnan
May 5, 2001·Pharmacology & Therapeutics·S V ArgyropoulosD J Nutt
Feb 26, 1998·Journal of Affective Disorders·J P FeighnerM K McPherson
May 20, 2003·Psychiatry and Clinical Neurosciences·Mei-Chun Hsiao, Chia-Yih Liu
Aug 10, 2004·The Australian and New Zealand Journal of Psychiatry·Louise HeuzenroederTheo Vos
Jul 12, 2002·Drugs·John J SramekNeal R Cutler
Dec 14, 2002·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN World Federation of Societies Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders
Sep 6, 2006·Child and Adolescent Psychiatric Clinics of North America·David A Brent, Boris Birmaher
Nov 10, 2006·Journal of Affective Disorders·Uriel Halbreich, Linda S Kahn
Mar 28, 2013·Human Psychopharmacology·Dan J SteinSidney H Kennedy
Jul 25, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders
Jul 27, 1999·Current Opinion in Chemical Biology·K A MaubachR G Hill
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
May 25, 2005·Journal of Geriatric Psychiatry and Neurology·Erin L CassidyJavaid I Sheikh
Dec 1, 2000·Depression and Anxiety·J P Staab, D L Evans
Dec 1, 2000·Depression and Anxiety·J Kaufman, D Charney
Dec 1, 2000·Depression and Anxiety·J M Gorman, L A Papp
Sep 10, 2003·Depression and Anxiety·David L DunnerMichael J Detke
May 17, 2006·Journal of Clinical Psychopharmacology·Jonathan DavidsonJeff J Musgnung
Apr 25, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN WFSBP Task Force on Unipolar Depressive Disorders
Dec 16, 2000·The British Journal of Psychiatry : the Journal of Mental Science·N FreemantleP Young
Dec 17, 2003·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Peter H Silverstone, Erica von Studnitz
Oct 27, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Sabine C HerpertzUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.